Articles in Scholarly Journals [Incomplete List]

1. Ruminative coping among patients with dysthymia before and after pharmacotherapy
   Depression and Anxiety, vol. 24, no. 4, pp. 233–243, 2007
2. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: Moderation by social stressors
   Brain, Behavior, and Immunity, vol. 21, no. 4, pp. 477–489, 2007
3. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior
   Behavioural Brain Research, vol. 179, no. 1, pp. 133–140, 2007
4. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice
   Behavioural Brain Research, vol. 181, no. 2, pp. 180–190, 2007
5. Rumination: Bridging a gap between forgivingness, vengefulness, and psychological health
   Personality and Individual Differences, vol. 42, no. 8, pp. 1573–1584, 2007
6. Interferon-a effects are exaggerated when administered on a psychosocial stressor backdrop: Cytokine, corticosterone and brain monoamine variations
   Journal of Neuroimmunology, vol. 186, no. 1-2, pp. 45–53, 2007
7. The limits of 'adaptive' coping: Well-being and mood reactions to stressors among women in abusive dating relationships
   Stress, vol. 10, no. 1, pp. 75–91, 2007
8. The Moderating Role of Ethnic Identity and Social Support on Relations Between Well-Being and Academic Performance
   Journal of Applied Social Psychology, vol. 37, no. 3, pp. 592–615, 2007
9. Involvement of Interferon-  in Microglial-Mediated Loss of Dopaminergic Neurons
   Journal of Neuroscience, vol. 27, no. 12, pp. 3328–3337, 2007
10. Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB1 Receptor Actions on Anxiety through Alterations of Serotonin Activity
    Journal of Neuroscience, vol. 26, no. 41, pp. 10387–10396, 2006
11. Calpain-Regulated p35/cdk5 Plays a Central Role in Dopaminergic Neuron Death through Modulation of the Transcription Factor Myocyte Enhancer Factor 2
    Journal of Neuroscience, vol. 26, no. 2, pp. 440–447, 2006
12. Corticotropin-Releasing Hormone, Arginine Vasopressin, Gastrin-Releasing Peptide, and Neuromedin B Alterations in Stress-Relevant Brain Regions of Suicides and Control Subjects
    Biological Psychiatry, vol. 59, no. 7, pp. 594–602, 2006
13. Maternal programming of defensive responses through sustained effects on gene expression
    Biological Psychology, vol. 73, no. 1, pp. 72–89, 2006
14. Maternal factors and monoamine changes in stress-resilient and susceptible mice: Cross-fostering effects
    Brain Research, vol. 1111, no. 1, pp. 122–133, 2006
15. Effects of acute or chronic omega-3 and omega-6 polyunsaturated fatty acid treatment on behavioral, neuroendocrine and cytokine changes elicited by exogenous interleukin-1ß challenge
    Journal of Neuroimmunology, vol. 181, no. 1-2, pp. 19–28, 2006
16. The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat
    Psychopharmacology, vol. 189, no. 3, pp. 287–296, 2006
17. The Buffering Role of Social Support Perceptions in Relation to Eating Disturbances among Women in Abusive Dating Relationships
    Sex Roles, vol. 54, no. 9-10, pp. 627–638, 2006
18. Stress, depression, and anhedonia: Caveats concerning animal models
    Neuroscience & Biobehavioral Reviews, vol. 29, no. 4-5, pp. 525–546, 2005
19. The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity
    Neuroscience, vol. 135, no. 3, pp. 659–678, 2005
20. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
    Proceedings of the National Academy of Sciences, vol. 102, no. 14, pp. 5215–5220, 2005
21. Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
    Current Pharmaceutical Design, vol. 11, no. 8, pp. 947–962, 2005
22. Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
    Current Pharmaceutical Design, vol. 11, no. 8, pp. 963–972, 2005
23. The effects of cortisol administration on social status and brain monoaminergic activity in rainbow trout Oncorhynchus mykiss
    Journal of Experimental Biology, vol. 208, no. 14, pp. 2707–2718, 2005
24. Parental bonding and depressive affect: The mediating role of coping resources
    British Journal of Social Psychology, vol. 44, no. 3, pp. 371–395, 2005
25. Coping With Employment Uncertainty: A Comparison of Employed and Unemployed Workers.
    Journal of Occupational Health Psychology, vol. 10, no. 3, Article ID 2005-08222-002, 9 pages, 2005
26. Working and Reference Memory in Seizure-Prone and Seizure-Resistant Rats: Impact of Amygdala Kindling.
    Behavioral Neuroscience, vol. 118, no. 2, Article ID 2004-12681-007, 9 pages, 2004
27. Anticipatory Cues Differentially Provoke In Vivo Peptidergic and Monoaminergic Release at the Medial Prefrontal Cortex
    Neuropsychopharmacology, vol. 29, no. 8, Article ID 1300441, 9 pages, 2004
28. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release
    European Journal of Neuroscience, vol. 20, no. 1, pp. 229–239, 2004
29. Amygdala amino acid and monoamine levels in genetically Fast and Slow kindling rat strains during massed amygdala kindling: a microdialysis study
    European Journal of Neuroscience, vol. 20, no. 1, pp. 185–194, 2004
30. Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
    Journal of Neuroscience, vol. 24, no. 8, pp. 2045–2053, 2004
31. Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region
    Journal of Neuroscience, vol. 24, no. 6, pp. 1478–1485, 2004
32. Corticosterone Changes in Response to Stressors, Acute and Protracted Actions of Tumor Necrosis Factor-α, and Lipopolysaccharide Treatments in Mice Lacking the Tumor Necrosis Factor-α p55 Receptor Gene
    Neuroimmunomodulation, vol. 11, no. 4, pp. 241–246, 2004
33. Influence of Chronic Interleukin-2 Infusion and Stressors on Sickness Behaviors and Neurochemical Change in Mice
    Neuroimmunomodulation, vol. 11, no. 5, pp. 341–350, 2004
34. Considering cytokine panels
    Brain, Behavior, and Immunity, vol. 18, no. 3, pp. 221–222, 2004
35. Neurochemical sensitization associated with systemic administration of tumor necrosis factor-a: adjuvant action in combination with bovine serum albumin
    Journal of Neuroimmunology, vol. 145, no. 1-2, pp. 91–102, 2003
36. Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli
    Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 8, pp. 1201–1212, 2003
37. Impact of chronic intermittent challenges in stressor-susceptible and resilient strains of mice
    Biological Psychiatry, vol. 53, no. 4, pp. 292–303, 2003
38. Impact of life-long macronutrient choice on neuroendocrine and cognitive functioning in aged mice: differential effects in stressor-reactive and stressor-resilient mouse strains
    Brain Research, vol. 985, no. 2, pp. 187–197, 2003
39. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
    Proceedings of the National Academy of Sciences, vol. 100, no. 23, pp. 13650–13655, 2003
40. Cytokines, stress and depressive illness: brain-immune interactions
    Annals of Medicine, vol. 35, no. 1, pp. 2–11, 2003
41. Stress and Cytokine-elicited Neuroendocrine and Neurotransmitter Sensitization: Implications for Depressive Illness
    Stress: The International Journal on the Biology of Stress, vol. 6, no. 1, pp. 19–32, 2003
42. Systems of Coping Associated with Dysphoria, Anxiety and Depressive Illness: A Multivariate Profile Perspective
    Stress: The International Journal on the Biology of Stress, vol. 6, no. 3, pp. 223–234, 2003
43. Anxiety in Rats Selectively Bred for Fast and Slow Kindling Rates: Situation-Specific Outcomes
    Stress: The International Journal on the Biology of Stress, vol. 6, no. 4, pp. 289–295, 2003
44. Sensitization associated with stressors and cytokine treatments
    Brain, Behavior, and Immunity, vol. 17, no. 2, pp. 86–93, 2003
45. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice
    Neurobiology of Disease, vol. 12, no. 2, pp. 150–161, 2003
46. Cytokines as a stressor: implications for depressive illness
    The International Journal of Neuropsychopharmacology, vol. 5, no. 4, pp. 357–373, 2002
47. Stress, immunity, cytokines and depression
    Acta Neuropsychiatrica, vol. 14, no. 6, pp. 251–261, 2002
48. The acute and sensitization effects of tumor necrosis factor-alpha: implications for immunotherapy as well as psychiatric and neurological conditions
    Acta Neuropsychiatrica, vol. 14, no. 6, pp. 322–335, 2002
49. Cytokines, stress, and depressive illness
    Brain, Behavior, and Immunity, vol. 16, no. 5, pp. 513–524, 2002
50. Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes
    Brain, Behavior, and Immunity, vol. 16, no. 5, pp. 544–556, 2002
51. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms
    European Journal of Neuroscience, vol. 15, no. 6, pp. 1061–1076, 2002
52. Changes in extracellular levels of amygdala amino acids in genetically fast and slow kindling rat strains
    Brain Research, vol. 946, no. 1, pp. 31–42, 2002
53. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load
    Brain Research, vol. 953, no. 1-2, pp. 82–92, 2002
54. Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data
    Journal of Affective Disorders, vol. 71, no. 1-3, pp. 121–130, 2002
55. Murine tumor necrosis factor-a sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine
    Journal of Neuroimmunology, vol. 131, no. 1-2, pp. 60–69, 2002
56. Role of bombesin-related peptides in the mediation or integration of the stress response
    Cellular and Molecular Life Sciences (CMLS), vol. 59, no. 2, pp. 272–287, 2002
57. Individual differences in sucrose consumption in the rat: motivational and neurochemical correlates of hedonia
    Psychopharmacology, vol. 157, no. 3, pp. 269–276, 2001
58. Bombesin-induced HPA and sympathetic activation requires CRH receptors
    Peptides, vol. 22, no. 1, pp. 57–65, 2001
59. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-a
    Neuroscience, vol. 106, no. 1, pp. 137–148, 2001
60. Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure
    Brain Research, vol. 892, no. 2, pp. 293–300, 2001
61. Differential impact of predator or immobilization stressors on central corticotropin-releasing hormone and bombesin-like peptides in Fast and Slow seizing rat
    Brain Research, vol. 906, no. 1-2, pp. 60–73, 2001
62. Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects
    European Journal of Neuroscience, vol. 13, no. 6, pp. 1155–1165, 2001
63. c-Jun mediates axotomy-induced dopamine neuron death in vivo
    Proceedings of the National Academy of Sciences, vol. 98, no. 23, pp. 13385–13390, 2001
64. Central Bombesin Activates the Hypothalamic-Pituitary-Adrenal Axis
    Neuroendocrinology, vol. 73, no. 3, pp. 203–214, 2001
65. Posttraumatic Stress Symptoms and Salivary Cortisol Levels
    American Journal of Psychiatry, vol. 158, no. 9, pp. 1509–1511, 2001
66. Central Monoamine Activity following Acute and Repeated Systemic Interleukin-2 Administration
    Neuroimmunomodulation, vol. 8, no. 2, pp. 83–90, 2000
67. Dysthymia: a review of pharmacological and behavioral factors
    Molecular Psychiatry, vol. 5, no. 3, pp. 242–261, 2000
68. Acoustic startle and fear-potentiated startle in rats selectively bred for fast and slow kindling rates: relation to monoamine activity
    European Journal of Neuroscience, vol. 12, no. 12, pp. 4405– 4416, 2000
69. Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1ß system, tumor necrosis factor-a, transforming growth factor-ß1, and neuropeptide mRNAs in specific brain regions
    Brain Research Bulletin, vol. 51, no. 2, pp. 187–193, 2000
70. A prospective study of neuroendocrine and immune alterations associated with the stress of an oral academic examination among graduate students
    Psychoneuroendocrinology, vol. 25, no. 4, pp. 339–356, 2000
71. Synergistic Effects of Interleukin-1ß, Interleukin-6, and Tumor Necrosis Factor-a Central Monoamine, Corticosterone, and Behavioral Variations
    Neuropsychopharmacology, vol. 22, no. 6, pp. 566–580, 2000
72. Kindling modulates the IL-1ß system, TNF-a, TGF-ß1, and neuropeptide mRNAs in specific brain regions
    Molecular Brain Research, vol. 75, no. 2, pp. 248–258, 2000
73. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features
    Journal of Affective Disorders, vol. 58, no. 1, pp. 1–10, 2000
74. Alterations in immune functions during normal aging and Alzheimer's disease
    Psychiatry Research, vol. 85, no. 1, pp. 71–80, 1999
75. Short- and long-periods of neonatal maternal separation differentially affect anxiety and feeding in adult rats: gender-dependent effects
    Developmental Brain Research, vol. 113, no. 1-2, pp. 97–106, 1999
76. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment
    Neuroscience, vol. 88, no. 3, pp. 823–836, 1999
77. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls
    Journal of Affective Disorders, vol. 52, no. 1-3, pp. 1–10, 1999
78. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects
    Brain Research, vol. 818, no. 2, pp. 291–303, 1999
79. Influence of psychogenic and neurogenic stressors on neuroendocrine and central monoamine activity in fast and slow kindling rats
    Brain Research, vol. 840, no. 1-2, pp. 65–74, 1999
80. Interleukin-1ß production in dysthymia before and after pharmacotherapy
    Biological Psychiatry, vol. 46, no. 12, pp. 1649–1655, 1999
81. Influence of acute tryptophan depletion on mood and immune measures in healthy males
    Psychoneuroendocrinology, vol. 24, no. 1, pp. 99–113, 1999
82. Role of bombesin-related peptides in the control of food intake
    Neuropeptides, vol. 33, no. 5, pp. 376–386, 1999
83. Self-Stimulation from the Mesencephalon Following Intraventricular Interleukin-2 Administration
    Brain Research Bulletin, vol. 45, no. 6, pp. 549–556, 1998
84. Do early-life events permanently alter behavioral and hormonal responses to stressors?
    International Journal of Developmental Neuroscience, vol. 16, no. 3-4, pp. 149–164, 1998
85. Differential effects of interleukin (IL)-1ß, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
    Brain Research, vol. 779, no. 1-2, pp. 177–187, 1998
86. Neural plasticity, neuropeptides and anxiety in animals — implications for understanding and treating affective disorder following traumatic stress in humans
    Neuroscience & Biobehavioral Reviews, vol. 23, no. 2, pp. 301–318, 1998
87. An assessment of the effects of central interleukin-1ß, -2, -6, and tumor necrosis factor-a administration on some behavioural, neurochemical, endocrine and immune parameters in the rat
    Neuroscience, vol. 84, no. 3, pp. 923–933, 1998
88. Influence of interleukin-1β on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice
    Psychopharmacology, vol. 137, no. 4, pp. 351–361, 1998
89. Influence of a Psychogenic and a Neurogenic Stressor on Several Indices of Immune Functioning in Different Strains of Mice
    Brain, Behavior, and Immunity, vol. 12, no. 1, pp. 7–22, 1998
90. Neuroendocrine and anthropometric measures in major depression: the effect of antidepressant treatment
    Human Psychopharmacology: Clinical and Experimental, vol. 12, no. 6, pp. 583–589, 1997
91. Influence of Psychogenic and Neurogenic Stressors on Endocrine and Immune Activity: Differential Effects in Fast and Slow Seizing Rat Strains
    Brain, Behavior, and Immunity, vol. 11, no. 1, pp. 63–74, 1997
92. Chronic stressors and depression: distinguishing characteristics and individual profiles
    Psychopharmacology, vol. 134, no. 4, pp. 330–332, 1997
93. ARE BOMBESIN-LIKE PEPTIDES INVOLVED IN THE MEDIATION OF STRESS RESPONSE?
    Life Sciences, vol. 62, no. 2, pp. 103–114, 1997
94. Differential Effects of Immunologic Challenge on Self-Stimulation From the Nucleus Accumbens and the Substantia Nigra
    Pharmacology Biochemistry and Behavior, vol. 58, no. 4, pp. 881–886, 1997
95. Effects of interleukin-1? and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study
    Brain Research, vol. 761, no. 2, pp. 225–235, 1997
96. Neuroendocrine measures and lymphocyte subsets in depressive illness: Influence of a clinical interview concerning life experiences
    Psychoneuroendocrinology, vol. 22, no. 4, pp. 225–236, 1997
97. Variations of lymphocyte subsets associated with stress in depressive populations
    Psychoneuroendocrinology, vol. 21, no. 8, pp. 659–671, 1996
98. Stressor-induced alterations of the splenic plaque-forming cell response: Strain differences and modification by propranolol
    Pharmacology Biochemistry and Behavior, vol. 53, no. 2, pp. 235–241, 1996
99. Primary dysthymia: A study of several psychosocial, endocrine and immune correlates
    Journal of Affective Disorders, vol. 40, no. 1-2, pp. 73–84, 1996
100. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors
     Psychopharmacology, vol. 128, no. 3, pp. 227–239, 1996
101. Stress-induced disturbances in Morris water-maze performance: Interstrain variability
     Physiology & Behavior, vol. 58, no. 1, pp. 57–65, 1995
102. Stressful life events and coping styles in relation to dysthymia and major depressive disorder: Variations associated with alleviation of symptoms following pharmacotherapy
     Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 19, no. 4, pp. 637–653, 1995
103. Central catecholamine alterations induced by stressor exposure: analyses in recombinant inbred strains of mice
     Behavioural Brain Research, vol. 63, no. 1, pp. 25–33, 1994
104. Influence of change from grouped to individual housing on a T-cell-dependent immune response in mice: Antagonism by diazepam
     Pharmacology Biochemistry and Behavior, vol